ClinicalTrials.gov
ClinicalTrials.gov Menu

Effectiveness of Topical Glycerine Sulphate Paste, Hirudoid Cream and Nil Application on Superficial Phlebitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01226069
Recruitment Status : Completed
First Posted : October 21, 2010
Last Update Posted : October 21, 2010
Sponsor:
Information provided by:
Tan Tock Seng Hospital

Brief Summary:
The aim of the interventional study is to compare the different treatment modalities in reducing erythema size and rate of resolving phlebitis.

Condition or disease Intervention/treatment Phase
Infection Drug: Glycerine Magnesium sulphate paste Drug: Mucopolysaccharide polysulphate Other: No application Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 147 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: To Investigate the Effectiveness of Topical Glycerine Sulphate, Hirudoid Cream and Nil Application in Treating Peripheral Cannula Related Phlebitis
Study Start Date : November 2009
Actual Primary Completion Date : February 2010
Actual Study Completion Date : February 2010

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Active Comparator: Glycerine Magnesium Sulphate paste Drug: Glycerine Magnesium sulphate paste
Dosage to apply adheres to the manufacturer's recommendation. Sufficient amount should cover the erythema size. Dose frequency is 12 hourly.

Active Comparator: Hirudoid cream
Topical Mucopolysaccharide polysulphate
Drug: Mucopolysaccharide polysulphate
Dosage to apply adheres to the manufacturer's recommendation. Sufficient amount should cover the erythema size. Dose frequency is 12 hourly.

Experimental: No application
Patient will not receive any topical application to apply on the phlebitis site. The outcome assessor will monitor regularly at pre-determined schedule as patients in other active arms.
Other: No application
No application




Primary Outcome Measures :
  1. Erythema size [ Time Frame: 5 days ]
    The incremental percentage change in erythema size


Secondary Outcome Measures :
  1. Time to resolve redness [ Time Frame: 5 days ]
    The rate of phlebitis resolution



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   21 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients admitted to the study institution between Dec 2009 and Feb 2010 and observed to develop redness associated with peripheral infusion cannula.

Exclusion Criteria:

  • Thrombosis, poor skin condition, and pus seen at the previous puncture.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01226069


Locations
Singapore
Tan Tock Seng Hospital
Singapore, Singapore, 308433
Sponsors and Collaborators
Tan Tock Seng Hospital
Investigators
Principal Investigator: Isabel Ng, MSc Epidemiology Tan Tock Seng Hospital

Publications of Results:
Responsible Party: Isabel Ng Hui Leng, Tan Tock Seng Hospital
ClinicalTrials.gov Identifier: NCT01226069     History of Changes
Other Study ID Numbers: D/09/481
First Posted: October 21, 2010    Key Record Dates
Last Update Posted: October 21, 2010
Last Verified: October 2010

Keywords provided by Tan Tock Seng Hospital:
superficial phlebitis
cannula-related vein inflammation
Glycerine magnesium sulphate
Hirudoid cream
Nursing

Additional relevant MeSH terms:
Phlebitis
Peripheral Vascular Diseases
Vascular Diseases
Cardiovascular Diseases
Vasculitis
Magnesium Sulfate
Glycerol
Heparinoids
Analgesics
Sensory System Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Anesthetics
Central Nervous System Depressants
Anti-Arrhythmia Agents
Anticonvulsants
Calcium Channel Blockers
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Tocolytic Agents
Reproductive Control Agents
Cryoprotective Agents
Protective Agents
Anti-Inflammatory Agents
Anticoagulants